Microbiology & Virology Market Growing at 4.9% CAGR to Reach USD 15.0 Billion Forecast to 2035

WiseGuy Reports, Nov. 2025 (Press Release) – Microbiology & Virology Market Global Outlook:

Global Microbiology & Virology Market Growth Research and Competitive Trends Analysis Report By Application (Diagnostics, Therapeutics, Vaccine Development, Research & Development), By End Use (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Research Institutions), By Type of Testing (Microbial Identification Testing, Antimicrobial Susceptibility Testing, Molecular Diagnostics, Viral Load Testing) and By Regional Size, Share, and Forecast to 2035

The Microbiology & Virology Market is experiencing strong global expansion, driven by rising infectious disease cases, technological advancements in laboratory diagnostics, and accelerated investment across pharmaceutical and biotechnology R&D. According to the latest industry research, the Microbiology & Virology Market Size stood at USD 8.89 Billion in 2024, is estimated to reach USD 9.33 Billion in 2025, and is projected to achieve USD 15.0 Billion by 2035, exhibiting a robust CAGR of 4.9% during the 2025–2035 forecast period. This growth is fueled by increased demand for rapid diagnostics, personalized medicine, high-throughput testing, and advanced microbial and viral detection technologies in clinical, industrial, and research settings.

The competitive landscape features leading global manufacturers and research-driven organizations, including Thermo Fisher Scientific, Becton Dickinson, Danaher Corporation, bioMérieux, Agilent Technologies, Abbott Laboratories, Qiagen, PerkinElmer, Merck KGaA, Luminex, Sysmex Corporation, Eppendorf, Charles River Laboratories, Roche Diagnostics, Genomatica, and Siemens Healthineers. These companies continue to introduce advanced pathogen detection systems, expand R&D programs, and accelerate the integration of AI, automation, and next-generation molecular technologies across microbiology and virology workflows.

Growing awareness about early disease diagnosis, pandemic preparedness, and improving healthcare infrastructure—especially in emerging economies—further strengthen the Microbiology & Virology Market Global Outlook. Governments, NGOs, and major health organizations are significantly increasing investments to enhance diagnostic readiness, outbreak surveillance, and laboratory modernization worldwide.

Download Free Sample Report: https://www.wiseguyreports.com/sample-request?id=735504

Segmental Analysis of the Microbiology & Virology Market

The market is segmented across Application, End Use, Type of Testing, and Region, offering a detailed view of evolving market trends and growth drivers.

By Application

Key application areas include:

• Infectious disease diagnostics
• Environmental testing
• Industrial microbiology
• Pharmaceutical quality control
• Research & academic studies
• Viral load testing
• Epidemiology and public health surveillance

Infectious disease diagnostics holds the largest market share due to rising viral outbreaks, increased antimicrobial resistance (AMR), and global surveillance requirements.

By End Use

Major end users include:

• Hospitals & Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes & Academic Centers
• Food & Environmental Testing Agencies

Hospitals and diagnostic labs dominate the market, driven by high patient testing volumes and rapidly evolving clinical diagnostic technologies.

By Type of Testing

The market encompasses a wide range of advanced testing methodologies:

• Culture-based microbial testing
• Molecular diagnostics (PCR, RT-PCR)
• Immunoassays
• Serological testing
• Next-generation sequencing (NGS)
• Microbial identification systems
• Viral load monitoring equipment

Molecular diagnostics is the fastest-growing segment due to its accuracy, rapid turnaround times, and expanding role in precision medicine and genomics-based solutions.

Purchase Full Market Report:

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735504

Key Market Dynamics

Rising Infectious Disease Prevalence

Increasing global outbreaks, viral epidemics, and AMR threats are driving demand for rapid microbiology and virology testing solutions.

Technological Advancements

Breakthroughs such as automated PCR systems, AI-based pathogen identification, NGS platforms, and high-throughput analyzers are transforming diagnostic speed and accuracy.

Growing Research Funding

Governments and private organizations continue to invest in pathogen surveillance, viral biology research, vaccine development, and AMR monitoring, creating significant market opportunities.

Pharmaceutical & Biotechnology R&D Growth

The rise in vaccine, biologics, and antiviral drug development enhances demand for advanced microbiology and virology platforms in R&D, quality control, and manufacturing.

Shift Toward Personalized Medicine

Precision therapies require molecular-level pathogen profiling and advanced viral load monitoring, strengthening long-term market projections.

Regional Analysis

The Microbiology & Virology Market covers North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA).

North America

North America leads global market share supported by:

• High R&D funding
• Early adoption of cutting-edge diagnostics
• Strong presence of leading manufacturers
• Advanced public health surveillance programs

The U.S. remains the largest market, driven by its world-class biotechnology ecosystem.

Europe

Europe experiences stable and strong growth due to:

• Widespread laboratory automation
• High healthcare investments
• Strong clinical research institutions
• Advanced healthcare infrastructure

Germany, France, and the U.K. dominate regional market revenue.

Asia-Pacific (APAC)

APAC is the fastest-growing region, fueled by:

• High infectious disease burden
• Large patient population
• Rising investments in healthcare modernization
• Expanding biotech and pharmaceutical sectors

China, India, Japan, and South Korea are major contributors to regional acceleration.

South America

Steady growth is driven by rising healthcare modernization and increased diagnostics adoption across Brazil, Mexico, and Argentina.

Middle East & Africa (MEA)

MEA presents emerging growth opportunities with rising government funding for diagnostic infrastructure, especially in GCC countries and South Africa.

Key Market Opportunities

• Rising infectious diseases and emerging viral threats
• Expanding pharmaceutical and biotech R&D
• Growing adoption of molecular diagnostics and NGS
• AI-driven pathogen detection and automated lab workflows
• Strengthened global disease surveillance infrastructure
• Increased vaccine development and biologics manufacturing

Browse Complete Premium Microbiology & Virology Market Growth Research and Competitive Trends Analysis Report https://www.wiseguyreports.com/reports/microbiology-virology-market

Reasons To Buy the Digital Front Microbiology & Virology Market Report:

➼ In-depth analysis of the Microbiology & Virology Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Related Research insights from Wise Guy Reports:

Health Physical Examination Market

Heparin Sodium Active Pharmaceutical Ingredient Market

Guillain-Barré Syndrome Market

Hospital Vacuum Cleaner Market

Hospital Flow Meter Market

HD Endoscopic Camera System Market

Inflammatory Skin Diseases Drugs Market

Hepatocyte Growth Factor HGF Antibody Market

Hepatic Antiviral Drug Market

Handheld Ultrasound System Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation.